Lv46
662 积分 2022-01-22 加入
Vebreltinib in MET amplification-driven advanced non-small-cell lung cancer (KUNPENG): a single-arm, multi-cohort, multicentre, phase 2 study
1个月前
已完结
Antitumor Activity of Vebreltinib and Characterization of Clinicogenomic Features in Solid Tumors with MET Rearrangements
1个月前
已完结
Vebreltinib in MET amplification-driven advanced non-small-cell lung cancer (KUNPENG): a single-arm, multi-cohort, multicentre, phase 2 study
1个月前
已完结
Cell transcriptomic atlas of the non-human primate Macaca fascicularis
1个月前
已完结
Role of N‐glycosylation in EGFR ectodomain ligand binding
1个月前
已完结
Integrated analysis of the complete sequence of a macaque genome
1个月前
已完结
The evolving treatment landscape of metastatic urothelial cancer
1个月前
已完结
PDX models for functional precision oncology and discovery science
1个月前
已完结
Bystander effect in antibody-drug conjugates: Navigating the fine line in tumor heterogeneity
1个月前
已完结
Zongertinib in Previously Treated HER2 -Mutant Non–Small-Cell Lung Cancer
2个月前
已完结
皖公网安备34019202002308
